pNF-KB-Split PS Intein-C tTA
(Plasmid
#242035)
-
PurposeC_terminal segment of a blue_light_controlled split PS_intein tTA gene_expression system, co_expressing mCherry under an NF_KB_inducible promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 242035 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 |
Backbone
-
Vector backbonemEGFP-N1
- Backbone size w/o insert (bp) 3628
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSplit PS Intein-C tTA
-
Alt nameIntC1-Linker 1-VVD-Linker 2-VVD-Linker 3-IntC-SSS-tTA--T2A-mCherry
-
SpeciesSynthetic
-
Insert Size (bp)3868
-
MutationThe CMV promoter in the original vector was replaced with the NF-KB promoter, which was amplified from the pNL3.2.NF-KB-RE[NlucP/NF-KB-RE/Hygro] vector.
- Promoter NF-KB
-
Tag
/ Fusion Protein
- mCherry (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer pBR322ori-F
- 3′ sequencing primer SV40pA-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pNF-KB-Split PS Intein-C tTA was a gift from Vladislav Verkhusha (Addgene plasmid # 242035 ; http://n2t.net/addgene:242035 ; RRID:Addgene_242035) -
For your References section:
Photoswitchable intein for light control of covalent protein binding and cleavage. Baloban M, Manoilov KY, Karasev MM, Verkhusha VV, Shcherbakova DM. Nat Commun. 2025 Sep 11;16(1):8263. doi: 10.1038/s41467-025-63595-9. 10.1038/s41467-025-63595-9 PubMed 40935816